pharmaphorum

APRIL 26, 2021

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The partnership will be based on Jolly Good’s technology and Teijin’s strategic expertise, the companies said.

Hospitals 122

Hospitals 122

European Pharmaceutical Review

AUGUST 24, 2022

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. In total, there are 14 approved ADCs on the global market, all for oncology indications, and over 140 ADCs currently in clinical development.

Compounding 82

Compounding Pharmaceutical Companies Pharmaceutical Companies 82

pharmaphorum

DECEMBER 2, 2020

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training as a confectioner. It was a success, and set the pattern for the company’s future development. The “first industrial war” involved drug producers as much as weapons manufacturers.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

European Pharmaceutical Review

NOVEMBER 10, 2022

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). Advanced light microscopy techniques can be used to better understand complex medicines and establish new approaches for discovery and development. What constitutes a complex medicine? Figure 1 ).

Labelling 96

Labelling Compounding 96

Roots Analysis

AUGUST 28, 2022

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

52

52

European Pharmaceutical Review

DECEMBER 27, 2023

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. Being a cellular therapy that involves cell manipulation and molecular transfection – and above all, being a living drug – makes CAR T-cell therapy a somewhat challenging immunotherapy to manufacture in‑house.

Adverse Reactions 83

Adverse Reactions Immunization Medical Schools Chemotherapy 83

Pharma Marketing Network

JUNE 8, 2020

Even there, that’s impacted by some distortions around pbms and how hospitals radically markup those drugs, but that’s probably the one exception. Now, there’s a broader discussion, politically which we could get into is, you know, employer-based healthcare sort of an accident of history. Dave (HR): Which part?

Health and Personal Care Stores 40

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies 40